Avantor (AVTR) Stock Analysis

November 11, 2026

This is a peer-relative look at Avantor (AVTR): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Avantor (AVTR)
Profile Item	AVTR
Name	Avantor, Inc.
Country/Region	United States
GICS Sector	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Life Sciences Tools & Services
GICS Sub-Industry	Life Sciences Tools & Services
Market Capitalization	10.48 billion USD
Currency	USD
Exchange	NYSE
Listing Date	May 17, 2019
Security Type	Common Stock

Price Performance

Cumulative Growth

AVTR

GSPC

Avantor (AVTR) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Avantor (AVTR) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Avantor (AVTR) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Total Return (1Y)	36.41%	24.62%
Total Return (3Y, Annualized)	-5.02%	20.37%
Total Return (5Y, Annualized)	-16.62%	-4.02%

Risk Profile

Drawdown History

AVTR

GSPC

Avantor (AVTR) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Avantor (AVTR) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Volatility (1Y, Annualized)	43.39%	66.36%
Beta (5Y)	0.94	0.93
Max Drawdown (5Y)	-82.42%	-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. AVTR is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Sharpe Ratio (1Y)	0.74	0.36
Sortino Ratio (1Y)	1.17	0.58

Profitability

ROE (TTM)

Avantor (AVTR) posts ROE of 5.91%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.91%

Group distribution

Max: 109.18%
Q3: 6.23%
AVTR: 5.91%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

Largest peers

LLY: 86.02%
NVS: 24.33%
AZN: 22.57%
JNJ: 20.02%
AVTR: 5.91%
MRK: 5.06%
ABBV: --

Where Avantor (AVTR) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Avantor (AVTR) keeps 5.08% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.08%

Group distribution

Max: 18.05%
AVTR: 5.08%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

Largest peers

LLY: 31.90%
AZN: 17.68%
NVS: 17.49%
JNJ: 16.20%
ABBV: 15.67%
AVTR: 5.08%
MRK: 3.64%

Where Avantor (AVTR) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Avantor (AVTR) turns 8.19% of revenue into operating profit, roughly in line with the peer group’s normal operating margin range. Its core cost structure looks typical for the industry.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.19%

Group distribution

Max: 83.12%
Q3: 14.77%
AVTR: 8.19%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

Largest peers

LLY: 53.66%
ABBV: 39.59%
MRK: 35.22%
NVS: 34.27%
AZN: 29.57%
JNJ: 25.74%
AVTR: 8.19%

Where Avantor (AVTR) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
ROE (TTM)	5.91%	-26.66%
ROA (TTM)	2.83%	-12.50%
Net Margin (TTM)	5.08%	0.00%
Operating Margin (TTM)	8.19%	0.00%
Gross Margin (TTM)	31.59%	37.87%

Growth

Revenue Growth

Avantor (AVTR) grew revenue -3.41%, in the lower peer quartile. The top line is expanding more slowly than at most peers, which can reflect softer demand, lost share, or weaker pricing.

Avantor (AVTR): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Avantor (AVTR) grew earnings per share -175.00%, in the lower peer quartile. Per-share profits are advancing more slowly than at most peers, so margins, costs, or share count deserve a closer look.

Avantor (AVTR): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Revenue Growth (YoY)	-3.41%	11.45%
Revenue Growth (3Y CAGR)	-4.46%	9.94%
EPS Growth (YoY)	-175.00%	4.28%
EPS Growth (3Y CAGR)	--	4.17%

Financial Strength

Current Ratio (MRQ)

Avantor (AVTR) has current ratio of 1.89, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.89

Group distribution

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
AVTR: 1.89
Min: 0.10

Largest peers

AVTR: 1.89
LLY: 1.39
MRK: 1.35
JNJ: 1.02
AZN: 1.01
NVS: 0.88
ABBV: 0.87

Where Avantor (AVTR) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Avantor (AVTR) has debt-to-equity ratio of 0.63, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.63

Group distribution

Max: 1.42
Q3: 0.65
AVTR: 0.63
Median: 0.15
Q1: 0.02
Min: 0.00

Largest peers

NVS: 1.29
LLY: 1.23
MRK: 1.20
AZN: 0.66
AVTR: 0.63
JNJ: 0.55
ABBV: --

Where Avantor (AVTR) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Current Ratio (MRQ)	1.89	5.52
Debt / Equity (MRQ)	0.63	0.15
Net Debt / EBITDA	3.40	1.08

Dividends

Dividend Yield (TTM)

Avantor (AVTR) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution

AVTR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

NVS: 2.88%
ABBV: 2.40%
MRK: 2.29%
JNJ: 1.94%
AZN: 1.73%
LLY: 0.49%
AVTR: 0.00%

Where Avantor (AVTR) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Avantor (AVTR) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution

AVTR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

MRK: 343.43%
ABBV: 117.35%
NVS: 90.46%
JNJ: 80.12%
AZN: 45.38%
LLY: 21.71%
AVTR: 0.00%

Where Avantor (AVTR) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	0.00%	0.00%

Valuation

P/E Ratio (TTM)

Avantor (AVTR) trades at P/E ratio of 30.94, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.94

Group distribution

Max: 85.34
Q3: 43.46
AVTR: 30.94
Median: 26.69
Q1: 13.30
Min: 0.07

Largest peers

MRK: 148.21
ABBV: 50.05
LLY: 43.95
JNJ: 41.92
NVS: 31.02
AVTR: 30.94
AZN: 26.37

Where Avantor (AVTR) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Avantor (AVTR) trades at 1.58 on P/S ratio, in the lower sales-valuation quartile for its industry. That points to a cheaper revenue stream than most peers, with margin quality still doing the heavy lifting.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.58

Group distribution

Max: 58.18
Q3: 25.77
Median: 7.30
Q1: 3.01
AVTR: 1.58
Min: 0.01

Largest peers

LLY: 13.95
ABBV: 7.80
JNJ: 6.69
MRK: 5.37
NVS: 5.35
AZN: 4.63
AVTR: 1.58

Where Avantor (AVTR) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Avantor (AVTR) trades at 1.80 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.80

Group distribution

Max: 13.53
Q3: 6.54
Median: 3.25
AVTR: 1.80
Q1: 1.69
Min: -5.59

Largest peers

LLY: 29.96
NVS: 8.25
JNJ: 8.16
MRK: 8.06
AZN: 5.59
AVTR: 1.80
ABBV: -112.34

Where Avantor (AVTR) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Avantor (AVTR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: AVTR	Industry group median
P/E Ratio (TTM)	30.94	26.69
P/S Ratio (TTM)	1.58	7.30
P/B Ratio (MRQ)	1.80	3.25
Free Cash Flow Yield (TTM)	4.21%	-1.66%